D. Bichet Et Al. , "Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients," 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks , vol.105, California, United States Of America, 2012
Bichet, D. Et Al. 2012. Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients. 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks , (California, United States Of America).
Bichet, D., Boudes, P., El Din, S., Ezgu, F. S., Feliciani, C., Zampetti, A., ... Lourenco, C. M.(2012). Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients . 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks, California, United States Of America
Bichet, Daniel Et Al. "Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients," 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks, California, United States Of America, 2012
Bichet, Daniel Et Al. "Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients." 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks , California, United States Of America, 2012
Bichet, D. Et Al. (2012) . "Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients." 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks , California, United States Of America.
@conferencepaper{conferencepaper, author={Daniel Bichet Et Al. }, title={Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients}, congress name={8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks}, city={California}, country={United States Of America}, year={2012}}